MetLife Investment Management’s CorMedix CRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $451K | Buy |
36,638
+246
| +0.7% | +$3.03K | ﹤0.01% | 1726 |
|
|
2025
Q1 | $224K | Sell |
36,392
-3,023
| -8% | -$18.6K | ﹤0.01% | 2135 |
|
|
2024
Q4 | $319K | Buy |
39,415
+3,776
| +11% | +$30.6K | ﹤0.01% | 2041 |
|
|
2024
Q3 | $288K | Hold |
35,639
| – | – | ﹤0.01% | 2084 |
|
|
2024
Q2 | $154K | Buy |
35,639
+8,785
| +33% | +$38K | ﹤0.01% | 2397 |
|
|
2024
Q1 | $114K | Buy |
26,854
+3,149
| +13% | +$13.4K | ﹤0.01% | 2472 |
|
|
2023
Q4 | $89.1K | Hold |
23,705
| – | – | ﹤0.01% | 2653 |
|
|
2023
Q3 | $87.7K | Hold |
23,705
| – | – | ﹤0.01% | 2642 |
|
|
2023
Q2 | $94K | Buy |
+23,705
| New | +$94K | ﹤0.01% | 2715 |
|